Classification of neuropsychiatric medications by principal mechanism of action: a meaningful way to anticipate pharmacodynamically mediated drug interactions (part II).
Preskorn
Sheldon H
SH
Department of Psychiatry, University of Kansas School of Medicine-Wichita, USA.
D004347:Drug Interactions; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000145:classification / Q000493:pharmacokinetics* / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D011619:Psychotropic Drugs